 |
| On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week. |
Funding Opportunities NIH funding opportunities focusing on global health and foreign collaboration. - Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) (PAR-21-303)
Application Receipt Dates: Multiple dates, see announcement
Note: This opportunity is from Fogarty's mHealth program. The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems or analytics. NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or foreign components may apply. - Brazil Regional Prospective Observational Research in Tuberculosis (RePORT) (U01 Clinical Trial Not Allowed) (PAR-21-304)
Application Receipt Date: Not Applicable - Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required) (PAR-21-309)
Application Receipt Dates: Multiple dates, see announcement - Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional) (PAR-21-310)
Application Receipt Dates: Multiple dates, see announcement - Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed) (PAR-22-023)
Application Receipt Date: October 22, 2021 - Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1: Data Production Research and Development Centers (UM1 Clinical Trial Not Allowed)
(RFA-HG-21-029)
Application Receipt Date: November 1, 2021 - Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical Trial Not Allowed) (RFA-HG-21-030)
Application Receipt Date: November 1, 2021 - Leveraging Existing Data Resources for Computational Model and Tool Development to Discover Novel Candidate Mechanisms and Biomarkers for ADRD (R01 Clinical Trial Not Allowed) (RFA-NS-22-006)
Application Receipt Date: October 26, 2021 NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers. - Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes (NOT-AI-21-067)
- Notice of Special Interest (NOSI): Precision Imaging of Oral Lesions (NOT-DE-21-010)
- Notice of Special Interest: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders (NOT-DK-21-024)
| | Featured Fogarty News and Information NIH COVID-19 Funding and News | | |
Upcoming Deadlines More Information |
No comments:
Post a Comment